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ABSTRACT  Thrombokinase of the blood, while resembling enterokinase in its 
role of activator,  is more closeIy analogous to trypsin in its intrinsic  origin.  It 
probably arises from a plasma precursor; but it is different from plasmin (fibrin- 
olysin).  Like trypsin,  thrombokinase can activate prothrombin without the aid 
of other factors; however,  it  is potentiated  by platelets  plus  calcium.  Unlike 
certain  tissue  "thromboplastins,"  it does not sediment appreciably in 2 hours 
at 85,000 g.  Like trypsin,  it hydrolyzes p-toluenesulfonylarginine methyl ester 
(TAMe).  Chromatography  on  DEAE--cellulose  separated  thrombin  from 
thrombokinase. The TAMe esterase associated with the thrombokinase fractions 
was largely suppressed by soybean trypsin inhibitor, while that associated with 
the  thrombin  fractions  was  not.  Highly  purified  thrombokinase  was  used  as 
starting  material;  and  thrombokinase  was  eluted  in  the  last  major  protein 
band.  Under these conditions stepwise elution was as  effective as  gradient  in 
leading to further purification.  The product of 199 liters of bovine plasma was 
chromatographed  in  1 day; and  the  specific  activity was comparable  to that 
attained  previously by repeated electrophoretic fractionations.  The  assembled 
data suggest that the thrombokinase protein may be approaching homogeneity. 
For more than  half  a  century,  students  of blood  coagulation  have been in- 
spired and guided by advances in the knowledge of digestive enzymes. In 1899 
Schepowalnikow  (1),  working  in  Pawlow's  laboratory,  discovered  entero- 
kinase.  And  in  1904,  Morawitz  (2)  introduced  the  term,  thrombokinase,  to 
suggest that  the action of tissue juice on prothrombin  was analogous to  that 
of enterokinase on trypsinogen.  In the following year, Morawitz (3) recognized 
that not only tissue juice, but also the blood itself, could activate prothrombin. 
The responsible factor, intrinsic  to the blood, he also designated  as thrombo- 
kinase.  In this usage, he was followed by Mellanby (4),  by Collingwood and 
MacMahon  (5), and by Dale and Walpole (6). 
That  pancreatic  extract  could give rise to an intrinsic  activator of its own 
enzymes had been suggested by Vernon in  1901  (7). This and Vernon's later 
work (8) further indicated that the activator was distinct from the rennet en- 
zyme.  However, this  was not widely accepted  until  it was corroborated  and 
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clarified in the  1930's by Northrop and Kunitz.  Having crystallized the en- 
zymes and their precursors, they showed that the more important proteinase, 
trypsin, was the activator, while chymotrypsin had the rennet activity (9-14). 
Thus it appears that thromboldnase of the blood, while resembling entero- 
kinase in its role of activator, is more closely analogous to trypsin with respect 
to its intrinsic origin. Moreover, in slight modification of Eagle's analogy (15), 
thrombokinase of the blood activates prothrombin as trypsin activates chymo- 
trypsinogen. 
Not only are these activators analogous, but trypsin can replace thrombo- 
kinase  as  an  activator  of prothrombin.  It  had  been  known  since  1916-17 
(6,  16, 17) and reiterated in 1928 (18) that trypsin had a blood-clotting action. 
In  1932,  Northrop  and  Kunitz  reported  that  their  crystallized  trypsin  ac- 
celerated  the clotting of blood  (11).  Using their crystallized  trypsin,  Eagle 
and  Harris  (19)  found  that  it  could  activate  partially  purified  pro- 
thrombin,  apparently  without the aid  of calcium.  However,  Ferguson and 
Erickson  (20),  who also  used crystalline trypsin supplied by Northrop  and 
Kunitz,  added  the important observation that  cephalin and  calcium acted 
synergistically  with trypsin. This removed, in  1939,  the difficulty which Eagle 
(15) had sought to avoid in 1937,--that of considering the unlikely possibility 
that cephalin plus calcium had an action equivalent  to that of trypsin.  Since 
then, trypsin has been found to activate prothrombin which had been purified 
in a  variety of ways (21-24). 
These  developments intensified  the  search  for  a  blood  enzyme  with a 
trypsin-like clotting action  (25,  26).  The idea was entertained that  this en- 
zyme was identical with the fibrinolytic enzyme called plasmin by Christensen 
and MacLeod  (27);  but it was reported in  1946  (28)  that suitably purified 
fibrinolytic preparations did not activate prothrombin. 
The present writer,  working in Northrop's laboratory, noted in  1942  (29) 
that  a  certain  plasma  globulin  precipitate  contained  thrombokinase.  This 
merely confirmed an observation made in 1930 by Mellanby (30). Mellanby's 
work (31)  was further corroborated in that the prothrombin fraction, under 
appropriate conditions, became active "spontaneously" without the addition 
of extraneous activators. Moreover, the activation could occur in the presence 
of 0.026 M oxalate. Clearly, if contaminating thrombokinase were responsible 
for this activation, it must be capable of functioning in the presence of oxalate. 
And it should be possible to prepare such thrombokinase from this or related 
fractions.  These  considerations  led  to  the  purification  and  study of Mood 
thrombokinase in this laboratory during the past fifteen years.  By  1947  (32) 
it could be reported that certain preparations of thrombokinase did not show 
conspicuous fibrinolytic activity. 
Early results indicated that thrombokinase was probably an enzyme which 
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prothrombin without the addition of calcium, and  even in  the presence of 
oxalate (34).  Like trypsin, it could activate prothrombin  apparently without 
the help of any other biologic factor (21,  35).  But, when thrombokinase was 
present as prime activator, production of thrombin was much faster if platelet 
material or cephalin was included. On the other hand, if thrombokinase was 
absent,  platelets plus calcium were ineffective (36).  Although  ionic calcium 
was not required for  the action of thrombokinase,  it was necessary for the 
accessory effect of platelets or cephalin: 
Basic reaction  Accessory factors 
Prothrombin  Thrombokinase) Thrombin  Ca  ++, platelets  (or cephalin) 
This is reminiscent of the idea put forth many years ago by Leathes and 
Mellanby (37)  and later by Macfarlane (38)  that cephalin was  a  coenzyme 
for  thrombokinase.  The  mechanism of the  accessory effect  is  still  not  well 
understood. However, the effect is a large one, consistent with the well known 
practical importance of platelets and calcium ions. 
In favor of the view that thrombokinase of the blood might be a  molecule 
about the size of trypsin, rather than a macromolecular particulate like some 
tissue  "thromboplastins,"  it  was found  that  thrombokinase  did  not  appre- 
ciably sediment in 2 hours at 85,000 g  (39). Its further resemblance to trypsin 
was suggested by the fact that soybean  trypsin inhibitor suppressed  the pro- 
duction of thrombin by a  mixture of prothrombin and thrombokinase. The 
general "anti-thromboplastic" effect of the soybean inhibitor had long been 
known (40--43). 
Meanwhile, it had been noted, in  1948 (44)  that alpha p-toluenesulfonyl- 
L-arginine methyl ester was a very sensitive substrate for trypsin. And in 1954, 
p-toluenesulfonylarginine methyl ester  (TAMe)  was reported  to  be  a  good 
substrate for plasmin (45)  and for thrombin  (46).  Sherry, Troll, and Glueck 
(47)  recognized the possibility that TAMe might also be a  substrate  for the 
natural activator of prothrombin. And in  1959, Arscott, Koppel, and Olwin 
(48)  reported that thromboplastin-generating systems containing plasma and 
serum components showed TAMe esterase characteristics. 
The  method  now  used  in  this  laboratory  for  preparation  of  purified 
thrombokinase yields only about  1.2 mg/liter of plasma;  but the activity of 
this material is easily measurable when diluted back to the volume of parent 
plasma (49). Repeated fractionations by continuous flow electrophoresis have 
led  to  material  which  gave  a  single  peak  (50),  with  values  for  protein, 
thrombokinase,  and  TAMe  esterase  closely  parallel.  More  recently  (51), 
purification comparable to that achieved by repeated electrophoresis has been 
accomplished more efficiently by chromatography on DEAE-cellulose (52). 
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procedure,  and  further  observations  on  the  trypsin-like  nature  of thrombo- 
kinase. 
EXPERIMENTAL 
Materials and Methods 
D~AE-CELLUr.OSE  N,N-Diethylaminoethylcellulose,  Eastman  Organic  Chemi- 
cals Rochester, New  York. 40 gm was washed  on  a  Buchner funnel with 1 liter of 
normal sodium hydroxide, followed by many liters of 0.05 M NaC1 : 0.02 M Na2HPO4 
until the pH was below 9.0.  It was then dispersed in the foregoing solution to make 
1 liter of suspension. A  new shipment was used for the column of Fig.  2.  With this 
new batch, packing was more difficult, and flow was faster. 
SOYBEAN  TRYPSIN INHIBITOR  Crystallized  five  times  by  Worthington  Bio- 
chemical Laboratory, Freehold, New Jersey, according to the method of Kunitz (53). 
Stock solution dialyzed against the Tris buffer used for assay of TAMe esterase. 
ESTIMATION OF PROTEIN  Method of Lowry et al.  (54). 
ASSAY OF Tm~O~BOraNASE  Working assay, as described (49), but with addition 
of simultaneous tests on a working standard, stored at -- 18°C. Although assays were 
performed in the presence of calcium ions, the capacity of chromatographed thrombo- 
kinase to function in the presence of 0.01 M oxalate was  verified by tests on the peak 
fraction of Fig. 2. This corroborated past experience with chromatographic fractions 
(51). 
ASSAY Or THRO~IN  Essentially as described (49). 
ASSAY Ot, TAME ESaXRASE  Method of Sherry and Troll (46). In experiments with 
soy inhibitor the enzyme was  incubated with  the inhibitor for 30 minutes  at 37°C 
before the  substrate  was  added.  There was  a  control preliminary incubation with 
buffer, in a  test to which no inhibitor was  added. Control activity was usually lower 
with this preincubation than without it. 
Gradient Elution of Thrombokinase 
The  routine  preparation  of thrombokinase  in  this  laboratory  yields  an  iso- 
electric  precipitate  which  is  dissolved  in  weakly  buffered salt  solution  (49). 
Continuous flow electrophoresis of this material at pH  8.6 has revealed three 
major protein  bands,  of which  the kinase  band  migrated  most rapidly  (55). 
This suggested  that  thromboldnase  would  be  among  the  last  proteins  to  be 
eluted from DEAE-cellulose; for Sober et al. had observed a  general trend to- 
ward  higher  electrophoretic  mobility  in  successive  fractions  eluted  by  de- 
creasing pH  and increasing salt gradient  (56).  It so happened that thrombo- 
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phosphate buffers, applied in stepwise fashion (51).  It remained to be seen 
whether gradient elution would result in greater resolution. 
A column, 19 mm in diameter and about 14 cm high, was prepared with a suspension 
ot 6 gm DEAE-cellulose.  At 4°C  automatic collection  of fractions at 60 drops per 
fraction was begun, as 40 ml of thrombokinase, at the stage of redissolved isoelectric 
precipitate, was introduced into the column. Immediately after the kinase, fluid was 
led into the column from a  500 ml centrifuge bottle used as mixing chamber con- 
taining 300 rnl 0.05 •  NaCI: 0.02 M Na2HPO4. This in turn received fluid from a  1 
liter Erlenmeyer flask containing 900 ml  1.0 M phosphate, pH 8.1.  Under pressure, 
the effluent emerged at 11.4 ml per hour. 
As seen in Fig.  1,  protein appeared in three major bands and the kinase 
was associated with the third band. At its peak the kinase activity was 29.5 
times that of the working standard; and the ratio of kinase activity to protein 
concentration was  118. This ratio for the five best kinase fractions was  114, 
118, 95,  108, and 107, respectively, with an average value of 108. These figures 
were in the same range of values as those which were being attained at that 
time by stepwise elution.  Gradient elution therefore offered no obvious ad- 
vantage in resolution. 
The concentration gradient was reflected in the specific conductance of the 
fractions, which began to rise conspicuously with fraction 36, at 179 ml. These 
conductance values were converted to  molarity of phosphate by use of an 
empirical graph. From these data, it could be estimated that kinase began to 
emerge when the phosphate was about 0.10 M and that elution was practically 
complete  when  it  was  0.40  W.  Independently, stepwise  elution  on  several 
columns had set these limits at 0.12M phosphate and 0.40 M phosphate, when 
the pH was maintained near 8.0. 
Stepwise Elution of Thrombokinase 
Previously (51),  stepwise elution had  given good results  even  though there 
were only two chief kinase fractions. As will be seen below and in Fig. 2, reso- 
lution was not significantly improved by dividing the kinase band into more 
fractions. 
A column 19 mm in diameter and about 22 cm high, was prepared with a suspension 
of 6 gm DEAE-cellulose.  Flow rate was maintained at 80 ml per hour by pressure; and 
the entire run was completed in 1 day at 4°C. Manual collection of I0 ml fractions 
was begun as  199  ml  of thrombokinase, representing the  product of 199  liters  of 
plasma,  at the stage  of redissolved  isoelectric  precipitate, was introduced into the 
column. This was followed  by 200 ml 0.12  M phosphate, pH 8.0,  and then 200 ml 
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As shown by Fig. 2, there was a  good separation of thrombin from thrombo- 
kinase.  But  the  separation  was  not  perfect.  A  trace  of kinase,  too  small  to 
show in the figure, began to appear at 239 ml, as eluant B began to emerge. A 
small  amount  of thrombin  also appeared in  some of the kinase fractions.  In 
varying  degree,  this  separation  was previously achieved  by ammonium  sul- 
fate  precipitation  (34)  and  by  continuous  electrophoresis  (55).  But  the 
chromatographic separation is the most efficient yet tried. 
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FIGURE 1. Gradient  elution of thrombokinase from DEAE-cellulose. Effluent volume, 
milliliters. Protein,  milligrams per milliliter. Kinase, activity per milliliter, relative to 
working standard. M, molarity of phosphate. 
For the seven best fractions,  the ratio of kinase activity to protein was  121, 
125,  132,  140,  146,  133,  and  132, respectively, with an average value of 133. 
This  represented  a  twofold purification ,  since  the ratio  for the starting  ma- 
terial  was  68.  This  ratio  did  not vary enough  among  the seven fractions  to 
indicate  significant  resolution  within  that  band.  Therefore,  the spur  on  the 
left side of the kinase peak in Fig.  2 is attributed  to an irregularity in column 
flow, rather  than  to another  component.  This interpretation  is substantiated 
by the parallelism of the values for protein, kinase, and esterase in this region. 
The seven best fractions together contained  71 per cent of the original kinase 
activity in 35.5 per cent of the original  volume; i.e.,  thrombokinase was con- 
centrated by the procedure.  These results offer the basis for a  simple chroma- 
tographic step in the purification of thrombokinase. J. H. MILSTONE  Thrombokinase  as Trypsin-Like Enzyme  io9 
TAMe Esterase Activity of Thrombokinase Fractions 
The close association of TAMe esterase with thrombokinase through repeated 
electrophoretic fractionations has been demonstrated (50,  55). The five main 
electrophoretic fractions  of the purest  material  had,  respectively,  399,  359, 
338, 333, and 325 TAMe esterase units per milligram protein, with an average 
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Flotra~ 2.  Stepwise  elution of thrombokinase from DEAE-ceUulose.  A, thrombokinase 
in 0.05 M  sodium chloride: 0.02 M  phosphate, pH 7.8; B, 0.12 M  phosphate, pH 8.0; C, 
0.40 M  phosphate, pH 8.0. Effluent volume, milliliters. Protein, milligrams per milliliter. 
Thrombin, NIH units per milliliter. Kinase, activity per milliliter, relative to working 
standard. Esterase, TAMe units per milliliter. 
value of 337.  The two chief kinase fractions yielded by a  previous chromato- 
graphic procedure averaged 347  units  per milligram  (51).  The seven main 
kinase fractions of Fig.  2  had an average value of 996  TAMe esterase units 
per milligram protein.  In view of the comparable levels reached by different 
methods and  the experience with repeated electrophoretic fractionations, it 
seems possible that practically all the esterase activity of the kinase band be- 
longs to the kinase protein. These data also suggest that the protein may be IIO  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  45  "  I962 
approaching homogeneity, as  do  the data  on specific kinase activity of the 
fractions. 
How  much of the  TAMe  esterase of the  thrombin  band  belongs  to  the 
thrombin is left open. However, there is an interesting difference between the 
esterase activity of the two bands of Fig. 2. In Table I, it is seen that the TAMe 
esterase  activity of a  thrombin  fraction  (F15)  was  unaffected  by  soybean 
trypsin inhibitor in a  concentration of 2.0 mg per ml. This is in accord with 
the results obtained with thrombin by Sherry and Troll (46). 
On the other hand, the esterase activity of the  peak kinase fraction  (F48) 
is mostly suppressed by the soy inhibitor at 0.2 mg per rnl and still more so by 
2.0 nag per rnl.  This is in harmony with the fact that the soy inhibitor sup- 
TABLE  I 
EFFECT  OF  SOYBEAN TRYPSIN  INHIBITOR 
ON  HYDROLYSIS  OF TAME 
Soy inhibitor  F15 (Thrombin)  F48 (Kinase) 
rag. per ml.  ml. 0.02 N  NaOH  ml. 0.02 N  NaOH 
0.0  1.10  1.19 
0.2  1.14  0.35 
2.0  1.07  0.17 
Values in the body of the table represent formol titratiom of groups liberated by hydrolysis. The 
concentration of inhibitor is given in milligrams per milliliter of buffer--enzyme-inhibitor-substrate 
mixture. 
pressed the direct, unaided activation of prothrombin by thrombokinase (39). 
Moreover, the results of Table I  make it unlikely that the soy inhibitor exerts 
its effect by acting on the substrate; for there the substrate is still available to 
the thrombin fraction.  The most plausible interpretation is  that  the soy in- 
hibitor reacts with the enzyme, thrombokinase. 
DISCUSSION 
While  evidence  is  accumulating  that  thrombokinase  bears  similarities  to 
trypsin, there are also differences. Preliminary tests for casein digestion in this 
laboratory (57) have suggested that the proteolytic activity of thrombokinase 
may be slight compared to that of trypsin. 
Trypsin frequently does not act appreciably on native proteins  (58);  and 
this  may prove to  be  true for  thrombokinase.  A  solution of bovine plasma 
albumin is used as a  diluent in the assay of bovine thrombokinase (49).  Al- 
bumin actually enhances the assay, which indicates that it does not act as an 
effectively competing  substrate  for  the  kinase.  This  is  appropriate  physi- 
ologically;  for  thrombokinase  must  activate  prothrombin  in  a  natural  en- 
vironment of albumin molecules which are in great numerical preponderance. j. H. MILSTONE  Thrombokinase  as Trypsin-Like Enzyme  III 
Correspondingly, it  might be  physiologically advantageous for  thrombo- 
kinase  to  be  relatively  insusceptible  to  much  of  the  antitryptic  power 
of plasma. It was reported ten years ago (34) that some preparations of serum 
protein depress the activation of prothrombin by trypsin, but exert little in- 
fluence on the activation of prothrombin by thrombokinase. 
Then again, there are degrees of similarity in the response to inhibitors. In 
different  amounts,  and  under  different  conditions,  the  crystalline  trypsin 
inhibitor from pancreas  (14)  has  exerted  no  (29),  little  (59),  or  moderate 
(60)  effect on the activation of prothrombin. Against certain prothrombin- 
activating systems, the soy inhibitor has been effective although the pancreatic 
inhibitor has not (22).  Soybean trypsin inhibitor largely blocks the action of 
purified thrombokinase, whether the substrate is prothrombin or TAMe. 
The capacity to hydrolyze TAMe is a  property shared not only with tryp- 
sin, but also with a  few enzymes from the plasma (61). 
Many years ago (32, 33), results with partially purified materials led to the 
working hypothesis that  thrombokinase arose  autocatalytically from a  pre- 
cursor, as in the ease of trypsin. Certain subsequent observations (34, 35, 49) 
have been in accord with this hypothesis. This is one of the many aspects of 
the trypsin analogy which remain to be studied in detail. 
The writer was assisted by Nadia Oulianoff, Harriet F. Brown, and Thomas R. Saxton. 
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